Otrzymywanie cząstek sferycznych z oligomeru kwasu 3-hydroksymasłowego

A. Cebulska; Z. Jedliński

Published : 2022-08-30

Vol. 51 No. 6 (2006)

Preparation of spherical particles of 3-hydroxybutyric acid oligomer

A. Cebulska Z. Jedliński

Abstract

Aqueous dispersions of 3-hydroxybutyric acid oligomer (molecular weight 890) were prepared using two physical methods: by solvent evaporation or by solvent diffusion from the emulsion of oligomer solution. Organic solvents were selected from these what would be applied in the future for the production of non-steroid antiphlogistic drugs (CHCl3 or CH2Cl2 for evaporation method and acetone for diffusion method). Due to the projected applications of the aqueous dispersion obtained in medicine we strove for decrease in concentrations of additives used in the system i.e. dispersion stabilizer [poly(vinyl alcohol) - PVAL] and a solvent as well as for the preparation of the particles of diameter Ł 1 mm. The effects of several basic parameters of the process on the dimensions and monodispersity of prepared particles were investigated (Table 1-3, Fig. 1-4). These parameters were as follows: concentration of an oligomer in organic phase (symbol in the Tables [10HB/D]org), concentration of a stabilizer in a continuous phase ([PVAL]woda), ratio of dispersion and continuous phases (O/W) and agitation speed.

Keywords

oligomer kwasu 3-hydroksymasłowego ; cząstki sferyczne ; wymiary ; otrzymywanie 3-hydroxybutyric acid oligomer ; spherical particles ; dimensions ; preparation

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Zasady cytowania

Cebulska, A., & Jedliński, Z. (2022). Preparation of spherical particles of 3-hydroxybutyric acid oligomer. Polimery, 51(6), 436–441. Retrieved from https://ichp.vot.pl/index.php/p/article/view/1542

References

Wagner H. N., Sabistan D. C., McA'ffe J. G., Tow D. E., Stern H. S.: N. Engl J. Med. 1964,271,377.

[2] Scheffel U., Rhodes B. A., Natarajan T. K., Wagner H. N.: J. Nucl. Med. 1972, 13, 498.

[3] Dhal R K., Babu G. N.: Makromol Chem. Rapid Commun. 1985, 6, 91.

[4] Dinnela C., Lanzarini G., Zannoni M., Laus M.: Macromol Rapid Commun. 1994, 15, 909.

[5] Mateo C., Fernandez-Lorente G., Abian O., Fernandez-Lafuente R., Guisan J. M.: Biomacromolecules 2000, 10, 1021.

[6] Oh J.-T., Kim J.-H.: Enzijme Microb. Technol 2000, 27, 356.

[7] Perez C., Sanchez A., Putnam D., Ting D., Langer R., Alonso M. J.: J. Control Release 2001, 75, 211.

[8] Ravi Kumar M. N. V., Bakowsky U., Lehr C. M.: Biomaterials 2004,25,1771.

[9] Ribeiro S., HussainN., Florence A. T: Int. J. Pharm. 2005, 298, 354.

[10] Johnson O. L., Jaworowicz W., Cleland J. L., Bailey L., Charnis M., Duenas E.: Pharm Res. 1997,14,730.

[11] Constantino H. R., Johnoson O. L., Żale S. E.: J. Pharm. Sci. 2004, 93, 2624.

[12] Rembaum A., Yen S. P. S.: J. Macromol Sci.-Chem. 1979, A13, 606.

[13] Shimizu H., Fuji-moto K., Kawaguchi H.: Colloids Surfaces, A 1999,153, 421.

[14] Tomlinson E.: Int. J. Pharm. Tech. & Prod. Mjr. 1983, 4,49.

[15] Mehta R. C., Jeyanthi R., Calis S., Thanoo B. C., Burton K. W., DeLuca P. P: J. Control Release 1984, 29, 375.

[16] Kaetsu L, Yoshida M., Asano M., Yamanaka H., Imai K., Yuasa H., Mashimo T, Suzuki K., Katakai R., Oya M.: J. Control Release 1987,6,249.

[17] Cha Y, Pitt C. G.: J. Control Release 1989, 8,259.

[18] Cohen S., Yoshioka T., Lucarelli M., Hwang L. H., Langer R.: Pharm. Res. 1991, 8(6), 713.

[19] Shah N. H., Railkar A. S., Cshen F. C., Tarantino R., Kumar S., Murjani M., Palmer D., Infeld M. H., Malick A. W.: J. Control Release 1993, 27,139.

[20] Denkbas E. B., Kaitian X., Tuncel A., Piskin E.: J. Biomater. Sci. Polymer Edn 1994, 6(9), 815.

[21] McGee J. P, Davis S. S., O'Hagan D. T.: J. Control Release 1995, 34, 77.

[22] Boisdron-Celle M., Menei P. H., Benoit J. P: J. Pharm. Pharmacol 1995, 47, 108.

[23] Okothi H., Nakano M.: Chem. Pharm. Buli 1996, 44(1), 180.

[24] Łukaszczyk J.: Polimery 1996, 41, 434.

[25] Kassab A. Ch., Xu K., Denkbas E. B., Dou Y, Zhao S.: J. Biomater. Sci. Polym Edn 1997, 8(12), 947.

[26] El-Baseir M. M., Kellaway I. V Mer. J. Pharm. 1998,175,135.

[27] Liggins R. T, D'Amou S., Demetrick J. S., Machan L. S., Burt H. M.: Biomateria 2000, 21, 1959.

[28] Soppimath K. S., Aminabhavi T. M. Kulkarni A. R., Rudzinski W. E.: J. Control. Rel. 2001, 70,

[29] Hans M. L., Lowman A. M.: Curr. Opin. Solid St. A 2002, 6, 319.

[30] Panyam J., Labhasetwar V.: Adv. Drug Deliver. Rev. 2003, 55, 329.

[31] Hombreiro-Perez M., Siepmann J., Zinutti C., Łanprecht A., Ubrich N., Hoffman M., Bodmeier R., Maincei P: J. Control Release 2003, 88, 413.

[32] Thote A. J., Gupta I B.: Nanomed.: Nanotechnol, Biol, Med. 2005, l, 85.

[33] Słońkowski S., Gadzinowski M., Sosnowski S., Radomska-Galant L: Polimery 2005, 50, 546.

[34] Praca zbiorowa: „Chemia polimerów" (red. Florjańczyk Z., Penczek S., tom II OWPW Warszawa 1998.

[35] Brigger L, Dubernet C., Couvreur P: Adv. Drug Delw. Rev. 2002, 54, 631.

[36] Mu L., Fen S. S.: J. Control Release 2003, 86, 33.

[37] Brannon-Peppas L Blanchette J. O.: Adv. Drug Delw. Rev. 2004,56 1649.

[38] Mi L., Seow P-H., Ang S.-N., Feng S.-S.: Colloid Polym Sci. 2004 283, 58.

[39] Cegnar M., Kos J., Kristl J.: Eur. J. Pharm. Sc, 2004, 22, 357.

[40] Win K., Feng S.-S.: Biomaterials 2005, 26 2713.

[41] Dong Y, Feng S.-S.: Biomaterials 2005, 26, 6068.

[42] Prinzen F. W., Bassingthwaighte J. B.: Cardiovasc. Res. 2000 45,13.

[43] Yu Y, Sun Y: J. Chromatogr. A1999,855,129.

[44] Soda R, Tavassoli M.: Exp. Celi Res. 1983,145, 389.

[45] Gordon I. L., Dreyer W. J., Yen S. P S., Rembaum A.: Cell Immunol 1977, 28, 307.

[46] Mirro J., Schwartz J. F, Civin C. L: J. Immunol Methods 1981, 47, 39.

[47] Thomasin C., Nam-Trar H., Merkle H. P, Gander B.: J. Pharm. Sci. 1998, 87(3), 259

[48] Thomasin C., Merkle H. P, Gander B.: J. Pharm. Sci 1998, 87(3), 269.

[49] Boisdron-Celle M., Menei P H., Benoii J. P: J. Pharm. Pharmacol 1995, 47, 108.

[50] Celikaya E., Denkbas E. B., Piskin E.: J. Appl Polym. Sci. 1996, 61,1439.

[51] Conway B. R., Eyles J. E., Alpar H. O.: J. Control Release 1997, 49, 1.

[52] Kassab A. C., Piskin E.: J. Bioact. Compat. Pol 1999,14, 291.

[53] Gorner T, Gref R., Michenot D., Sommer F, Tran M. N., Dellacherie E.: J. Control Release 1999, 57, 259.

[54] Mu L., Feng S.-S.: J. Control Release 2002, 80, 129.

[55] Jaiswal J., Gupta S. K., Kreuter J.: J. Control Release 2004, 96, 169.

[56] Win K. Y, Feng S.-S.: Biomaterials 2005,26,2713.

[57] Liu M., Dong J., Yang Y, Yang X., Xu H.: Eur. Polym. J. 2005, 41, 375.

[58] Lee W, Parka J., Jung S., Yang C. W., Kim W.-U., Kim H.-Y, Park J.-H., Park J.: J. Control Release 2005,105, 77.

[59] Juni K., Nakano M., Kubo-ta M.: J. Control Release 1986,4,25.

[60] Koosha F, Miiller R. H., Davis S. S., Davies M. C.: J. Control. Release 1989, 9,149.

[61] Akhtar S., Pouton C. W, Notarianni L. J., Gould P. L.: J. Pharm. Pharmacol 1989, 41,5.

[62] Piddubnyak V., Kurcok P, Matuszowicz A., Głowala M., Fiszer-Kierzkowska A., Jedliński Z., Juzwa M., Krawczyk Z.: Biomaterials 2004, 25, 2571.

[63] Guidance for Industry Q3C Impurities: Residual Solvents!997.

Google Scholar

Citing articles via

Statistics

Total abstract views : 0

PDF Downloads : 0